Voquezna Will Be a New Rx Acid Suppressant

January 2024

Vonoprazan (Voquezna) will be a new Rx acid reducer.

It’s the first “potassium-competitive acid blocker” (PCAB).

Think of this as a fancy proton pump inhibitor (PPI). Both types of meds reduce acid to heal erosive GERD (gastroesophageal reflux disease)...but they work a bit differently.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Obesity & Weight Loss Avoid Mix-Ups With Meds for Weight Loss
Obesity & Weight Loss Zepbound Will Compete With Other Injectables for Obesity
Contraceptives Prepare for Opill, the First OTC Oral Contraceptive
Med Safety Include Directions for Oral Liquid Meds in “mL”
Insulin Help Patients on Levemir Switch to Another Insulin
Gastroenterology Voquezna Will Be a New Rx Acid Suppressant
Substance Use Disorder Prevent Mishaps With Meds for Alcohol Use Disorder
NatMed Spotlight Give Guidance About Coenzyme Q10

Voquezna Will Be a New Rx Acid Suppressant

Practical advice for a better career, with unlimited access to CE

Table of Contents